Literature DB >> 15803081

Histological evaluation of biopsies obtained from vertebral compression fractures: unsuspected myeloma and osteomalacia.

Daisuke Togawa1, Isador H Lieberman, Thomas W Bauer, Mary Kay Reinhardt, Mark M Kayanja.   

Abstract

STUDY
DESIGN: A histological evaluation of biopsies obtained from presumed osteoporotic vertebral compression fractures (VCF) to confirm possible osteomalacia after tetracycline labeling.
OBJECTIVE: To describe the results of a series of biopsies obtained at the time of vertebral augmentation in presumed osteoporotic VCF, with special reference to the presence of unmineralized bone (osteomalacia) and occult or unconfirmed plasma cell dyscrasia. SUMMARY OF BACKGROUND DATA: Vertebral augmentation is now widely performed as a method to treat osteoporotic or osteolytic VCF. However, the influence of underlying pathology on the effect of treatment is unclear.
METHODS: As of October 2003, 178 biopsies were obtained from 142 patients with VCF during 246 kyphoplasty procedures. There were 110 one-level, 28 two-level, and 4 three-level biopsies. Patients included 41 men and 101 women, with an average age of 72 years (range 40-90). The patients consented to this procedure, and 25 received tetracycline (1g/day, in 2 doses separated by 6 days). Vertebral body biopsies were taken using a trephine just before the kyphoplasty procedure. The biopsies were fixed, embedded, and stained with toluidine blue and hematoxylin eosin, and were viewed with transmitted light. Unstained sections were viewed under fluorescent light to detect tetracycline labels.
RESULTS: The 178 biopsy levels included: T4 (3), T5 (1), T6 (4), T7 (13), T8 (12), T9 (8), T10 (11), T11 (17), T12 (28), L1 (25), L2 (14), L3 (13), L4 (17), and L5 (12). All specimens showed fragmented bone with variable amounts of unmineralized bone (osteoid), suggesting bone remodeling and/or fracture healing. Woven bone and cartilaginous tissue were often present, representing fracture callus formation. The biopsies obtained from 30 patients (21%), including 4 who received tetracycline, showed significantly increased osteoid, suggesting either increased bone remodeling activity or mineralization defect (osteomalacia). One sample from these 4 patients who received tetracycline showed no tetracycline labels, essentially diagnostic of osteomalacia. The biopsies also provided definitive diagnoses for one case of unsuspected and 3 cases of unconfirmed plasma cell dyscrasia.
CONCLUSIONS: The majority of biopsies from this series of patients revealed findings consistent with various stages of fracture healing. Osteoid seams were increased in 30 patients, representing either increased bone remodeling or osteomalacia. More cases with tetracycline labeling will help elucidate the true incidence of osteomalacia in this population. As we confirmed 4 cases of plasma cell dyscrasia, we advocate a biopsy during each first-time vertebral augmentation procedure.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15803081     DOI: 10.1097/01.brs.0000157478.03349.57

Source DB:  PubMed          Journal:  Spine (Phila Pa 1976)        ISSN: 0362-2436            Impact factor:   3.468


  11 in total

1.  Characterization of eight different tetracyclines: advances in fluorescence bone labeling.

Authors:  Christoph Pautke; Stephan Vogt; Kilian Kreutzer; Cornelia Haczek; Gabriele Wexel; Andreas Kolk; Andreas B Imhoff; Horst Zitzelsberger; Stefan Milz; Thomas Tischer
Journal:  J Anat       Date:  2010-04-26       Impact factor: 2.610

2.  Coaxial biopsy during percutaneous vertebroplasty in patients with presumed osteoporotic vertebral compression fractures: retrospective review of biopsy results.

Authors:  C Venturi; S Barbero; C Tappero; V Ciccone; F Mastrogiacomo; L Molinaro; G Gandini
Journal:  Radiol Med       Date:  2010-10-06       Impact factor: 3.469

3.  Routine needle biopsy during vertebral augmentation procedures. Is it necessary?

Authors:  Spiros G Pneumaticos; Sofia N Chatziioannou; Christiana Savvidou; Anastasia Pilichou; Dimitra Rontogianni; Dimitrios S Korres
Journal:  Eur Spine J       Date:  2010-04-07       Impact factor: 3.134

4.  Management of vertebral re-fractures after vertebroplasty in osteoporotic patients.

Authors:  G Guarnieri; G Ambrosanio; M G Pezzullo; F Zeccolini; P Vassallo; R Galasso; A Lavanga; M Muto
Journal:  Interv Neuroradiol       Date:  2009-09-01       Impact factor: 1.610

5.  The role of routine transpedicular biopsies during kyphoplasty or vertebroplasty for vertebral compression fractures in the detection of malignant diseases: a systematic review.

Authors:  Georg Osterhoff; Max J Scheyerer; Ulrich J A Spiegl; Klaus J Schnake
Journal:  Arch Orthop Trauma Surg       Date:  2022-03-01       Impact factor: 3.067

6.  Histological evaluation of bone biopsy results during PVP or PKP of vertebral compression fractures.

Authors:  Lei Zhang; Jigang Li; Huilin Yang; Zongping Luo; Jun Zou
Journal:  Oncol Lett       Date:  2012-09-28       Impact factor: 2.967

7.  The intravertebral vacuum phenomen as specific sign of osteonecrosis in vertebral compression fractures: results from a radiological and histological study.

Authors:  Martin Libicher; Andreas Appelt; Irina Berger; Martin Baier; Peter-Jürgen Meeder; Ingo Grafe; Katharina Dafonseca; Gerd Nöldge; Christian Kasperk
Journal:  Eur Radiol       Date:  2007-05-24       Impact factor: 5.315

8.  The Diagnostic Value of Magnetic Resonance Imaging in Identifying Unsuspected Malignancy in Patients Undergoing Percutaneous Vertebral Augmentation for Vertebral Compression Fractures.

Authors:  Chew Zhihong; Cheng Sheng DA Jowell; Syed Aftab; Seang Beng Tan; Chang Ming Guo; John Chen Li Tat; Poh Ling Fong; William Yeo; Mashfiqul A Siddiqui
Journal:  Int J Spine Surg       Date:  2019-10-31

9.  Minimally invasive surgery for spinal fractures due to multiple myeloma.

Authors:  Rui Reinas; Djamel Kitumba; Leopoldina Pereira; Oscar L Alves
Journal:  J Craniovertebr Junction Spine       Date:  2021-06-10

10.  The value of routine biopsy during percutaneous kyphoplasty for vertebral compression fractures.

Authors:  Qiang Li; Surong Hua; Chu Wang; Siyi Cai; Jia Zhang
Journal:  PLoS One       Date:  2014-12-19       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.